Immunology researchers detect cytokine production in individual immune cells within laboratory settings during functional immune response studies. This specialized flow cytometry protocol enables single-cell cytokine analysis by stimulating cells, blocking protein transport, then staining intracellular cytokines. The process involves cell activation, permeabilization, and antibody staining to quantify cytokine-producing cells for
Laboratory researchers prepare cellular samples for flow cytometry analysis in research facilities during experimental workflows. This comprehensive protocol enables multiparameter immunophenotyping by optimizing cell staining, antibody binding, and sample preparation. The process involves cell isolation, surface marker staining, washing steps, and fixation to achieve high-quality data acquisition with minimal background
Researchers use red blood cell lysis to remove erythrocytes from rodent blood samples in laboratory settings during sample preparation. This technique eliminates interfering red blood cells while preserving nucleated cells for flow cytometry and immunophenotyping. The process involves treating samples with ACK buffer for 2-5 minutes, then washing to achieve
Despite affecting 77% of women by menopause, uterine fibroid research faces critical limitations due to inadequate animal models that fail to replicate human disease pathophysiology, genetic patterns, and tissue characteristics, forcing scientists to develop innovative three-dimensional cell culture alternatives for better treatment development.
Anilocus provides comprehensive mutagenicity testing services including bacterial mutation assays, mammalian cell gene mutation studies, and in vivo mutagenicity testing to assess genetic mutation potential and support regulatory submissions for drug development programs.
Anilocus provides comprehensive genotoxicity testing services including Ames test, micronucleus assay, chromosomal aberration studies, and comet assay to assess DNA damage potential and mutagenic risk for regulatory compliance and drug safety evaluation.
Anilocus provides specialized preclinical contract research organization (CRO) services to Basel’s biotech and pharmaceutical companies, offering comprehensive drug discovery support including in vivo studies, pharmacokinetics, pharmacodynamics, and regulatory compliance expertise. We accelerate research timelines for companies developing breakthrough therapies in Switzerland’s premier pharmaceutical hub.
Anilocus provides specialized preclinical contract research organization (CRO) services to Munich’s biotech and pharmaceutical companies, offering comprehensive drug discovery support including in vivo studies, pharmacokinetics, pharmacodynamics, and regulatory compliance expertise. We accelerate research timelines for companies developing breakthrough therapies in Germany’s leading biotechnology hub.
Anilocus provides comprehensive general toxicology studies including acute, subacute, and chronic toxicity testing with MTD determination, NOAEL estimation, and dose-range finding to evaluate drug safety and establish appropriate dosing parameters for regulatory submissions.
Anilocus provides comprehensive preclinical toxicology testing services including general toxicity, clinical pathology, genotoxicity, reproductive toxicology, and safety pharmacology studies to support drug development programs from early discovery through regulatory submission with expert scientific guidance.
Bold ideas and breakthrough research. Expert analysis on the innovations and drug development for the most important people in the world: patients.
Use this form to send your questions to our research team about our preclinical contract research services.
We are here to help!
